Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -6,424 | 3,434 | 12,817 | N/A |
| Depreciation Amortization | N/A | 1,138 | 764 | 381 | N/A |
| Accounts receivable | N/A | 1,664 | 1,664 | 143 | N/A |
| Other Working Capital | N/A | -23,261 | -24,642 | -23,526 | N/A |
| Other Operating Activity | 0 | -146 | -990 | -1,685 | 0 |
| Operating Cash Flow | $N/A | $-27,029 | $-19,770 | $-11,870 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -46 | -46 | -45 | N/A |
| Purchase Sale Intangibles | N/A | -845 | -663 | -507 | N/A |
| Other Investing Activity | 0 | -845 | -663 | -507 | 0 |
| Investing Cash Flow | $N/A | $-891 | $-709 | $-552 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 24,490 | 8,999 | 14 | N/A |
| Common Stock Repurchased | N/A | N/A | 68 | N/A | N/A |
| Other Financing Activity | 0 | 67 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $24,557 | $9,067 | $14 | $N/A |
| Beginning Cash Position | N/A | 45,118 | 45,118 | 45,118 | N/A |
| End Cash Position | N/A | 41,755 | 33,706 | 32,710 | N/A |
| Net Cash Flow | $N/A | $-3,363 | $-11,412 | $-12,408 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -27,029 | -19,770 | -11,870 | N/A |
| Capital Expenditure | N/A | -54 | -54 | -45 | N/A |
| Free Cash Flow | 0 | -27,083 | -19,824 | -11,915 | 0 |